Breast Cancer Clinical Trial

Massage Therapy for Breast Cancer Treatment-Related Swelling of the Arms

Summary

The purpose of this study is to examine the short-term and long-term efficacy of massage therapy alone compared to massage therapy plus compression bandaging in the treatment of breast cancer treatment-related swelling of the arms and legs.

View Full Description

Full Description

Massage therapy (in the form of manual lymph drainage [MLD]) and compression bandaging (CB) are integral components of combined physical therapy (CPT), the recommended treatment for peripheral lymphedema (LE). According to the World Health Organization, LE afflicts hundreds of millions worldwide and probably millions in the United States. Effects of various forms of massage on lymph circulation have been postulated for more than a century, but the efficacy of MLD alone without CB has not been demonstrated. New data suggest that MLD alone reduces established LE volume as effectively as CB in combination with CPT and minimizes LE development.

Patients will be randomly assigned to either treatment with MLD alone or a combination of MLD and CB. Patients will be treated in 10 one-hour sessions over 2 weeks. They will also undergo lymphangioscintigraphy (a nuclear medicine test) to depict the function of their lymphatic system. Patients will continue self treatment at home and will be followed for 6 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Lymphedema (5% to 20% increase in volume) after breast cancer treatment

Exclusion Criteria:

Physically unable to perform massage or bandaging during home program

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

88

Study ID:

NCT00058851

Recruitment Status:

Completed

Sponsor:

National Center for Complementary and Integrative Health (NCCIH)

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Arizona
Tucson Arizona, 85724, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

88

Study ID:

NCT00058851

Recruitment Status:

Completed

Sponsor:


National Center for Complementary and Integrative Health (NCCIH)

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider